SPPILawsuits•prnewswire•
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SPPI
Sentiment:Negative (-70)
Summary
NEW YORK, Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP announces the reopening of the Lead Plaintiff appointment process in a pending securities class action lawsuit on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI). Investors are advised...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 16, 2025 by prnewswire